Using a gene signature technique to tailor chemotherapy for patients with early triple negative breast cancer shows promise ...

Discoverer of Klotho gene further strengths KLTO Scientific Advisory BoardNEW YORK, Oct. 23, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: KLTO), a leading biotechnology company focused on developing cell and ...

(Alliance News) - Syncona Ltd on Wednesday noted positive trial results for a portfolio company's gene therapy aimed at treating people with Gaucher's disease.

Advancements in organoid technology are crucial for Parkinson's disease research, providing human-relevant models for ...

The incubator is designed to draw cell and gene therapy researchers and drugmakers to work at the hub, where they can develop ...

Unprecedented genome analysis ties brain structure variations to genetic risks for Parkinson’s disease and ADHD ...

A high dose of the investigational gene therapy AAV-GAD, which delivers the glutamic acid decarboxylase ( GAD) gene to the ...

Knowledge on the genetic basis of Parkinson's disease has grown tremendously since the discovery of the first monogenic form, ...

A Phase 3 clinical trial investigating Elevidys (delandistrogene moxeparvovec), a gene therapy for Duchenne muscular ...

MJFF launches initiative to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease: New York Saturday, October 19, 2024, 11:00 Hrs [IST] The Mic ...

SAVANNAH, Ga. -- Delandistrogene moxeparvovec (Elevidys), a gene therapy approved to treat Duchenne muscular dystrophy, ...

However, the modulation of neuronal signals is critical not only for treating circuit disorders but also for identifying ...